#history of #ribociclib getting approved in the #UK in only July of this year. #medicine #politics #cancer #ciclibs
on 02025-11-05“Recent progress of CDK4/6 inhibitors’ current practice in breast #cancer” from 02024. #ciclibs #medicine
on 02025-11-05“The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast #Cancer” from 02018 just after ribociclib was approved #ciclibs #medicine
on 02025-11-05